NVP-DKY709 is a potent and selective small molecule inhibitor of IKZF2 (Helios), a transcription factor implicated in immune suppression. It is utilized in cancer immunotherapy research to modulate Treg function and has demonstrated activity in both cellular assays and in vivo tumor models.